Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAMI-BAS
2024-511789-35-00Phase 4Authorised
- Sponsor
- Region Västra Götaland
- Start
- Jun 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bisoprolol, ramipril and dapagliflozin in myocardial infarction (MI) and cardiac ischemia, sponsored by Region Västra Götaland. Primary endpoint: Global longitudinal strain at day 7 adjusted for baseline. Planned start Jun 2024; status: authorised.
02
Drugs
bisoprololramiprildapagliflozin
03
Conditions
myocardial infarction (MI)cardiac ischemia
Beyond the preview
Go deeper on 2024-511789-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511789-35-00.